HELP US

STOP THE PROGRESSION

OF COVID-19

Have you been diagnosed with COVID-19? 

Do you have any of these symptoms? Cough or difficulty breathing, fever, muscle pain, loss of smell.You could be eligible to participate in the government-funded clinical trial called "COLCORONA".

A new coronavirus is responsible for causing coronavirus disease (COVID-19). While the majority of cases are mild, a certain number of people progress to severe disease with complications.

Adults who suffer major COVID-19 complications appear to present a major inflammatory storm (overreaction of immune system). Therefore, we hypothesize that targeting the inflammatory response (originating from the inflammasome) may reduce COVID-19-related complications in adults at risk or with evidence of an inflammatory storm.

The primary objective of the COLCORONA study is to determine whether short-term treatment with a particular medication reduces the rate of death and lung complications related to COVID-19. COLCORONA will be a randomized, double-blind, placebo-controlled study. Following signature of the informed consent form, 6000 subjects meeting all inclusion and no exclusion criteria will be enrolled.